Prostate Cancer

Stereotactic body radiotherapy induced high rates of biochemical control and low rates of severe toxicity among men with low- or intermediate-risk prostate cancer, according to results of a retrospective study published in JAMA Oncology. The results suggest that SBRT, which cuts treatment duration to 4 or 5 days, should be considered a standard option for these men. “Most men with low- or intermediate-risk prostate cancer undergo conventional radiation, which requires them to come in daily for treatment and takes an average of 9 weeks to complete,” Amar Kishan , MD, assistant professor of radiation oncology at David Geffen School of Medicine at University of California, Los Angeles, and researcher at UCLA Jonsson Comprehensive Cancer Center, said in a press release. “That can be very burdensome on a patient and be a huge interruption on their life. With the improvements being made to modern technology, we’ve found that stereotactic body radiotherapy ... can safely and effectivel...

Stereotactic body radiotherapy induced high rates of biochemical control and low rates of severe toxicity among men with low- or intermediate-risk prostate cancer, according to results of a retrospective study published in JAMA Oncology. The results suggest that SBRT, which cuts treatment duration to 4 or 5 days, should be considered a standard option for these men. “Most men with low- or intermediate-risk prostate cancer undergo conventional radiation, which requires them to come in daily for treatment and takes an average of 9 weeks to complete,” Amar Kishan , MD, assistant professor of radiation oncology at David Geffen School of Medicine at University of California, Los Angeles, and researcher at UCLA Jonsson Comprehensive Cancer Center, said in a press release. “That can be very burdensome on a patient and be a huge interruption on their life. With the improvements being made to modern technology, we’ve found that stereotactic body radiotherapy ... can safely and effectivel...

Greg Lawless was newly retired and living the good life – fly fishing, mountain biking, banjo playing – when he became one of the 175,000 men diagnosed with prostate cancer every year. “I thought, whoa, me?” Lawless said. “I exercise and I do all the healthy stuff that I’m supposed to do.” But it wasn’t a mistake. The truth is that besides skin cancer, prostate is the type of cancer most commonly diagnosed in American men . Once Lawless had learned about his cancer’s characteristics and the treatment options, he dove into research. Most Read Stories “I read every test and medical journal that I could find,” Lawless said. “I think I’m the only person who’s consistently read ‘Urology Magazine’ and wasn’t a urologist.” And Lawless learned that, “most modes of treatment would cure my prostate cancer, but it’s really the side effects that you have to focus on because there’s no guarantee that you won’t end up with impotence, incontinence, or rectal problems.” Lawless’ doctor who...

Greg Lawless was newly retired and living the good life – fly fishing, mountain biking, banjo playing – when he became one of the 175,000 men diagnosed with prostate cancer every year. “I thought, whoa, me?” Lawless said. “I exercise and I do all the healthy stuff that I’m supposed to do.” But it wasn’t a mistake. The truth is that besides skin cancer, prostate is the type of cancer most commonly diagnosed in American men . Once Lawless had learned about his cancer’s characteristics and the treatment options, he dove into research. Most Read Stories “I read every test and medical journal that I could find,” Lawless said. “I think I’m the only person who’s consistently read ‘Urology Magazine’ and wasn’t a urologist.” And Lawless learned that, “most modes of treatment would cure my prostate cancer, but it’s really the side effects that you have to focus on because there’s no guarantee that you won’t end up with impotence, incontinence, or rectal problems.” Lawless’ doctor who...

DURHAM, N.C. - Other than skin cancer, prostate cancer is the most common cancer in American men. That's why early detection is key.  Duke researchers say race plays an important role when it comes to risk and response to prostate cancer treatment.  Known as Hugh "Muddy Waters" Hargett on the football field in college, Hargett had trouble tackling the diagnosis of prostate cancer.  "I couldn't eat. I probably lost about 45 or 50 pounds," Hargett said. "One in nine men will be diagnosed with prostate cancer in their lifetime," said Dr. Daniel George, professor of medicine & Surgery at Duke Cancer Institute. George said even though there's been a decrease in prostate cancer cases, too many lives are still being lost. "Death from prostate cancer is at an all-time high -- 29,000 deaths a year in the United States," George said. African Americans are at a greater risk for developing the disease.  "And they are at a two a...

An international team of scientists has uncovered the unique set of genes that keeps some cancer cells dormant. Led by Associate Professor Tri Phan and Professor Peter Croucher at the Garvan Institute of Medical Research in Australia, in collaboration with Professor Ido Amit at the Weizmann Institute of Science in Israel, the research may reveal new therapeutic targets for multiple myeloma (a blood cancer that arises in bone) and other cancers which spread, or metastasise, to bone such as breast and prostate cancer. Most will associate cancer with its fast growing cells that spread uncontrollably -- but in fact, it's often the cancer cells that are dormant and inactive that pose the greatest threat. Dormant cancer cells, when 'woken up', are a major cause of cancers coming back, or relapsing, after treatment -- often as metastases, which are estimated to cause 90 per cent of all cancer deaths. A ticking time bomb When cancer metastasises, it spreads to different organs ...